ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102. A total of 62 filers reported holding ASTRIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,135,288 | -22.5% | 2,565,052 | -13.4% | 0.00% | 0.0% |
| Q2 2023 | $24,675,901 | -71.2% | 2,962,293 | -54.0% | 0.00% | -50.0% |
| Q1 2023 | $85,598,214 | +71.5% | 6,435,956 | +92.0% | 0.00% | -20.0% |
| Q4 2022 | $49,915,806 | +1362.9% | 3,352,304 | +788.2% | 0.01% | – |
| Q3 2022 | $3,412,000 | +201.4% | 377,445 | 0.0% | 0.00% | – |
| Q2 2022 | $1,132,000 | -52.3% | 377,445 | +6.7% | 0.00% | – |
| Q1 2022 | $2,375,000 | – | 353,884 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 911,736 | $8,060,000 | 2.93% |
| VR Adviser, LLC | 538,999 | $4,765,000 | 0.61% |
| COMMODORE CAPITAL LP | 239,270 | $2,115,000 | 0.56% |
| Perceptive Advisors | 1,959,652 | $17,323,000 | 0.25% |
| Cormorant Asset Management, LP | 552,903 | $4,888,000 | 0.20% |
| RA Capital Management | 1,262,193 | $11,158,000 | 0.16% |
| Soleus Capital Management, L.P. | 112,499 | $994,000 | 0.16% |
| ArchPoint Investors | 28,247 | $250,000 | 0.08% |
| Ikarian Capital, LLC | 87,580 | $775,000 | 0.06% |
| Old Well Partners, LLC | 12,116 | $107,000 | 0.06% |